Nicole B. Rockweiler

Apr 13, 2023 | science.org | Nicole B. Rockweiler |Laura M. MacLatchy |Xing Yuan |Margaret Hamburg

In the days since Texas federal judge Matthew J. Kacsmaryk invalidated the approval by the US Food and Drug Administration (FDA) of mifepristone, a medication used to terminate pregnancy, a shock wave of concern has swept through many people, organizations, and companies that work closely with the agency.